# Cytopoint Injection: Monoclonal Antibody Schedule and Duration


## Key Takeaways

-   Cytopoint (lokivetmab) is a caninized monoclonal antibody that targets and neutralizes canine Interleukin-31 (IL-31), a primary cytokine mediating pruritus in canine atopic dermatitis.
-   The onset of action is rapid, with significant pruritus reduction observed within 3 to 5 hours post-injection, facilitating swift relief from the itch-scratch cycle.
-   The duration of effect is dose-dependent and variable, typically lasting 4 to 8 weeks, with a statistically significant effect demonstrated for at least 28 days at the standard 2.0 mg/kg dose.
-   The standard administration schedule is a subcutaneous injection every 4 weeks, but this can be individualized to 6-8 week intervals based on the dog's sustained response, with some dogs experiencing prolonged control for up to a year.
-   Cytopoint is a targeted therapy with a wide safety margin, lacking the broad immunosuppressive effects of corticosteroids, and can be safely used in conjunction with other treatments for secondary infections or immunotherapy.
-   Proactive administration of Cytopoint has demonstrated efficacy in delaying or preventing flares of canine atopic dermatitis, with a median time to flare of 63 days in one study.

---

If your [dog](/knowledge/veterinary-medicine/clinical-methods/dog) suffers from allergic itch, you have likely discussed Cytopoint with your veterinarian. Cytopoint is the brand name for lokivetmab, a caninized monoclonal antibody that targets and neutralizes interleukin-31 (IL-31), a key cytokine responsible for transmitting itch signals in the skin. A single subcutaneous injection typically provides relief from pruritus within 24 hours, with effects lasting anywhere from 4 to 8 weeks, though some dogs may experience prolonged control. This article provides a definitive, evidence-based breakdown of the Cytopoint injection schedule, its onset of action, duration of effect, and what pet owners and veterinary professionals should expect during therapy.

**Owner-Facing Triage Summary:** If your dog is scratching, licking, or biting excessively, Cytopoint may be a safe and effective option. However, it is not an emergency medication. If your dog is in severe distress, has widespread skin infections, or is showing signs of systemic illness (fever, lethargy, loss of appetite), seek veterinary care immediately. For routine allergic itch, schedule a veterinary appointment to discuss whether Cytopoint is appropriate for your dog's specific condition.

## At a Glance: Cytopoint (Lokivetmab) Overview

| Feature | Description |
| :--- | :--- |
| **Active Ingredient** | Lokivetmab (caninized monoclonal antibody) |
| **Target** | Canine Interleukin-31 (cIL-31) |
| **Indication** | Control of pruritus associated with canine atopic dermatitis |
| **Route of Administration** | Subcutaneous injection |
| **Onset of Action** | Significant reduction in pruritus can be seen within 3 to 5 hours post-injection [<a href="#ref-1">1</a>] |
| **Duration of Effect** | Dose-dependent; statistically significant effect for up to 28 days at 2.0 mg/kg, with clinical effects often extending to 4-8 weeks [<a href="#ref-2">2</a>][<a href="#ref-1">1</a>] |
| **Dosing Schedule** | Typically administered once monthly, but can be individualized based on the dog's response and duration of effect |
| **Mechanism** | Binds to and neutralizes IL-31, preventing it from activating its receptor on sensory neurons, thereby blocking the itch signal [<a href="#ref-2">2</a>][<a href="#ref-3">3</a>] |

## Understanding Canine Atopic Dermatitis and Pruritus

Canine atopic dermatitis (CAD) is a complex, genetically predisposed, inflammatory, and pruritic allergic skin disease [<a href="#ref-3">3</a>]. It is one of the most common reasons for veterinary dermatology visits. The condition is often triggered by environmental allergens such as house dust mites, pollens, and molds. When a genetically susceptible dog is exposed to these allergens, their immune system overreacts, producing an inflammatory cascade that leads to intense itching (pruritus) and characteristic skin lesions [<a href="#ref-3">3</a>].

The clinical signs of CAD typically appear between 6 months and 3 years of age and may be seasonal or non-seasonal, depending on the offending allergens. Common signs include:

- Excessive scratching, rubbing, or licking
- Chewing on [paws](/knowledge/veterinary-medicine/clinical-methods/paws)
- Red, inflamed skin (erythema)
- Hair loss (alopecia)
- Recurrent skin or ear infections
- "Hot spots" (acute moist dermatitis)

The pathophysiology of the itch in CAD is complex, but Interleukin-31 (IL-31) has been identified as a central mediator [<a href="#ref-3">3</a>]. IL-31 is a cytokine, a signaling protein, that is released by immune cells (specifically Th2 cells) in the skin. It binds to receptors on sensory nerve fibers, directly triggering the sensation of itch. By understanding this pathway, veterinary medicine has developed a targeted biological therapy: lokivetmab.

## What is Cytopoint (Lokivetmab)?

Cytopoint is the trade name for lokivetmab, a caninized monoclonal antibody (mAb) designed specifically for use in dogs [<a href="#ref-2">2</a>][<a href="#ref-3">3</a>]. A monoclonal antibody is a laboratory-produced protein that mimics the immune system's ability to fight off harmful pathogens, but in this case, it is engineered to target a specific protein in the body.

Lokivetmab is "caninized," meaning its structure has been altered to be as close to a canine antibody as possible, minimizing the risk of the dog's immune system recognizing it as foreign and attacking it. This is a significant advantage over older, less species-specific biologics.

The target of lokivetmab is canine IL-31 (cIL-31) [<a href="#ref-3">3</a>]. By binding to and neutralizing cIL-31, lokivetmab acts like a sponge, soaking up the cytokine before it can bind to its receptors on nerve endings in the skin. This effectively "switches off" the itch signal at its source, providing relief from the relentless cycle of scratching and inflammation [<a href="#ref-2">2</a>][<a href="#ref-3">3</a>].

Historically, the production of such monoclonal antibodies has been a complex and costly process, typically done in mammalian cell cultures (CHO cells). Research is exploring more cost-effective production methods, such as using plant-based platforms, to make these treatments more accessible [<a href="#ref-3">3</a>].

## The Cytopoint Injection Schedule: What to Expect

The standard Cytopoint injection schedule is flexible and tailored to each individual dog, but it generally follows a monthly administration pattern.

### Initial Dosing and Onset of Action

The goal of initial therapy is to achieve rapid control of pruritus. In a controlled study using a model of IL-31-induced pruritus, a single subcutaneous dose of lokivetmab at 2.0 mg/kg demonstrated a significant reduction in pruritus within just 3 to 5 hours after administration [<a href="#ref-1">1</a>]. This rapid onset makes Cytopoint a valuable tool for quickly breaking the itch-scratch cycle.

### Maintenance and Re-dosing Schedule

After the initial injection, the duration of clinical effect is what determines the re-dosing interval. The manufacturer's recommendation is typically every 4 to 8 weeks, but this is highly individualized.

- **Standard Schedule:** Most dogs receive an injection every 4 weeks (monthly). This maintains a consistent level of the antibody in the bloodstream to continuously block IL-31.
- **Extended Interval:** Some dogs may experience a longer duration of effect, with relief lasting 6 to 8 weeks or longer. In these cases, the veterinarian may extend the interval between injections.
- **Proactive Therapy:** A study on proactive maintenance therapy investigated using lokivetmab to prevent flares in dogs whose atopic dermatitis was already controlled [<a href="#ref-2">2</a>]. In this study, dogs were treated with lokivetmab per the manufacturer's recommendations, and their median time-to-flare was found to be 63 days after discontinuing all other anti-allergic drugs [<a href="#ref-2">2</a>]. This suggests that for some dogs, the effect can last for about two months. Impressively, one-fourth of the dogs in that study did not have a flare for at least one year while receiving lokivetmab monotherapy [<a href="#ref-2">2</a>].

Your veterinarian will likely start with a standard monthly injection and then adjust the schedule based on when you observe the return of your dog's itching. If your dog starts scratching again at week 5, we know the duration is about 4 weeks, and the next injection should be scheduled accordingly.

### Dose-Dependent Duration

The duration of effect is also dose-dependent. In the IL-31 challenge model, researchers found that the duration of statistically significant effect was related to the dose administered [<a href="#ref-1">1</a>]. While the standard label dose is 2.0 mg/kg, the study showed that lower doses (0.125 and 0.5 mg/kg) had a shorter duration of effect (14 and 28 days, respectively) [<a href="#ref-1">1</a>]. This highlights why it is critical to use the correct, weight-based dose to achieve the desired duration of relief.

## Duration of Effect: How Long Does One Injection Last?

The duration of a single Cytopoint injection is not a fixed number. It varies based on the individual dog's metabolism, the severity of their disease, and the dose given.

- **Minimum Duration:** Clinical trials have shown that a 2.0 mg/kg dose provides a statistically significant reduction in pruritus for at least 28 days [<a href="#ref-1">1</a>].
- **Average Duration:** In practice, the effect typically lasts between 4 and 6 weeks.
- **Extended Duration:** As noted in the proactive therapy study, the median time to a flare was 63 days (approximately 9 weeks) [<a href="#ref-2">2</a>]. Some dogs can go much longer, with a subset of dogs not flaring for over a year [<a href="#ref-2">2</a>].

It is important to understand that Cytopoint does not cure the underlying allergy. It manages the symptom of itch. Once the antibody is used up by the body, the IL-31 can bind to its receptors again, and the itch will return. The goal is to re-dose before the itch becomes severe to maintain a good quality of life.

## Evidence-Based Management: What the Studies Show

The efficacy and duration of Cytopoint are well-supported by peer-reviewed veterinary research.

### Study 1: Proactive Maintenance Therapy

A 2019 study by Tamamoto-Mochizuki et al. investigated whether proactive administration of lokivetmab could prevent or delay flares of canine AD [<a href="#ref-2">2</a>].

- **Methodology:** The study had two parts. First, an experimental model using house dust mite (HDM)-sensitized dogs was used. These dogs were given one injection of lokivetmab, and seven days later, HDM was applied to their skin to trigger a reaction. In the second part, 21 dogs with spontaneous AD were treated with lokivetmab, and all other anti-allergic drugs were discontinued within four weeks. The dogs were followed for at least one year to measure the time-to-flare (TTF).
- **Key Findings:**
    - In the experimental model, one injection of lokivetmab prevented nearly all allergen-induced pruritus, but it did not prevent the development of skin lesions [<a href="#ref-2">2</a>].
    - In dogs with spontaneous AD, the median TTF was 63 days [<a href="#ref-2">2</a>].
    - 25% of the dogs did not flare for at least one year while on lokivetmab monotherapy [<a href="#ref-2">2</a>].
- **Clinical Relevance:** This study confirms that while lokivetmab is excellent at controlling the itch, it may not fully prevent the inflammatory skin lesions that are part of the allergic response. It also provides strong evidence for a proactive dosing strategy, where the injection is given before a flare is expected.

### Study 2: Onset and Duration of Action

A 2021 study by Fleck et al. was designed to precisely measure the onset and duration of action of lokivetmab in a controlled model of IL-31-induced pruritus [<a href="#ref-1">1</a>].

- **Methodology:** This was a randomized, blinded, placebo-controlled study. Twenty-four purpose-bred beagle dogs were given either a placebo, or 0.125, 0.5, or 2.0 mg/kg of lokivetmab subcutaneously. They were then challenged with IL-31 at various time points (3-5 hours, and 1, 7, 14, 28, 42, and 56 days post-dosing) to see if the lokivetmab could block the induced itch.
- **Key Findings:**
    - At the 2.0 mg/kg dose, a significant reduction in pruritus was observed within 3-5 hours of treatment [<a href="#ref-1">1</a>].
    - The duration of effect was dose-dependent. The effect lasted for 14 days at the 0.125 mg/kg dose, 28 days at the 0.5 mg/kg dose, and was statistically significant for at least 28 days at the 2.0 mg/kg dose [<a href="#ref-1">1</a>].
- **Clinical Relevance:** This study provides the most precise data on the onset and duration of action. It confirms that Cytopoint works very fast and that the standard dose of 2.0 mg/kg provides a solid month of itch control. It also underscores the importance of accurate dosing.

### Study 3: Plant-Based Production of Monoclonal Antibodies

A 2024 study by Morel et al. explored an alternative method for producing anti-IL-31 monoclonal antibodies using a plant-based platform (Nicotiana benthamiana) [<a href="#ref-3">3</a>].

- **Methodology:** Researchers produced a recombinant anti-IL-31 monoclonal antibody (M1) in plants and tested its activity in a canine model of pruritus, comparing it to the commercially available lokivetmab.
- **Key Findings:** Dogs treated with the plant-made M1 antibody showed similar improvements in pruritus to those treated with the commercial lokivetmab [<a href="#ref-3">3</a>].
- **Clinical Relevance:** This research is important for the future of veterinary medicine. It suggests that producing these life-changing biologics could become cheaper and faster, potentially increasing accessibility for pet owners. It also confirms the central role of IL-31 in the itch pathway [<a href="#ref-3">3</a>].

## Veterinary Examination and Diagnostics: Is Cytopoint Right for Your Dog?

Before prescribing Cytopoint, your veterinarian will perform a thorough examination to ensure it is the right treatment. The diagnosis of atopic dermatitis is often one of exclusion.

1.  **Physical Examination:** The veterinarian will assess the pattern of skin lesions, which often affects the paws, face, ears, and belly.
2.  **Rule Out Other Causes:** It is critical to rule out other causes of pruritus, such as:
    - Flea allergy dermatitis
    - Food allergy (adverse food reaction)
    - Sarcoptic mange (scabies)
    - Secondary bacterial or yeast skin infections
3.  **Diagnostic Tests:** Depending on the presentation, tests may include skin scrapings, cytology (to check for yeast/bacteria), and a trial of a hypoallergenic diet.
4.  **Allergy Testing:** Intradermal or serum allergy testing may be recommended to identify specific environmental allergens, especially if allergen-specific immunotherapy (allergy shots) is being considered.

Cytopoint is often chosen when the diagnosis is consistent with atopic dermatitis and other causes of itch have been ruled out. It is a safe and effective option for managing the itch while other diagnostic or therapeutic steps are taken.

## Safety, Side Effects, and Contraindications

Cytopoint is generally considered a very safe medication with a wide margin of safety.

- **Mechanism of Safety:** Because it is a caninized antibody targeting a specific cytokine (IL-31), it does not have the broad immunosuppressive effects of drugs like corticosteroids (e.g., prednisone). It does not suppress the entire immune system, making it a preferred option for long-term management.
- **Common Side Effects:** Side effects are uncommon but can include mild and transient lethargy, vomiting, or diarrhea. These are typically self-limiting.
- **Hypersensitivity Reactions:** As with any injectable biologic, there is a rare risk of an allergic reaction (anaphylaxis) to the injection itself. This is why injections are often given at the veterinary clinic, where the dog can be monitored.
- **Use with Other Medications:** Cytopoint can be safely used in conjunction with other therapies, such as antibiotics for secondary skin infections, medicated shampoos, and topical treatments. It is often used alongside allergen-specific immunotherapy.
- **Breed and Age:** It is approved for use in dogs of all breeds and ages. However, it is always best to discuss your dog's specific health history with your veterinarian.

## Unsafe Home Remedies and What to Avoid

When your dog is itchy, it is tempting to try home remedies. However, many can be harmful or ineffective.

- **Human Antihistamines:** While some human antihistamines are used in veterinary medicine, they are often ineffective for the severe itch associated with atopic dermatitis. Never give your dog any medication without veterinary approval, as dosing and safety can vary.
- **Hydrocortisone Creams:** Over-the-counter hydrocortisone creams are generally safe in small amounts but are not very effective for widespread itching. They can also be harmful if ingested in large quantities.
- **Essential Oils:** Many essential oils are toxic to dogs, especially when applied to damaged skin or ingested during grooming.
- **Oatmeal Baths:** While soothing, they only provide very temporary relief and do not address the underlying cause. They are not a substitute for medical therapy.

The most effective and safe approach is to follow your veterinarian's prescribed treatment plan.

## Prevention and Long-Term Management of Atopic Dermatitis

Cytopoint is a powerful tool for managing the symptoms of atopic dermatitis, but it is not a cure. Long-term management is a multi-modal approach.

- **Allergen Avoidance:** If specific allergens are identified, avoidance is the first line of defense. This may involve frequent washing of bedding, using air purifiers, and wiping your dog's paws after walks to reduce pollen exposure.
- **Skin and Coat Care:** Regular bathing with a gentle, veterinary-approved shampoo can help remove allergens from the skin and restore the skin barrier. Omega-3 fatty acid supplements can also support skin health.
- **Allergen-Specific Immunotherapy (ASIT):** This is the only disease-modifying treatment for atopic dermatitis. It involves giving your dog gradually increasing doses of the specific allergens they are allergic to, with the goal of desensitizing their immune system over time. Cytopoint can be used to manage the itch while ASIT takes effect, which can take several months to a year.
- **Regular Veterinary Check-ups:** Atopic dermatitis is a chronic condition that requires ongoing monitoring. Regular check-ups allow your veterinarian to adjust the treatment plan as needed and catch secondary infections early.

## Prognosis: What to Expect Long-Term

With appropriate management, the prognosis for dogs with atopic dermatitis is generally good. They can live a long, happy, and comfortable life.

- **Quality of Life:** The primary goal of therapy is to improve the quality of life for both the dog and the owner. Cytopoint can dramatically reduce pruritus and the associated skin damage, allowing for restful sleep and normal behavior.
- **Lifelong Management:** Atopic dermatitis is a lifelong condition. It requires a commitment to ongoing therapy. The frequency of Cytopoint injections may change over time, and other treatments may be added or removed.
- **The "One-Year" Outlook:** In the proactive therapy study, a significant portion of dogs (25%) did not experience a flare for at least one year on lokivetmab monotherapy [<a href="#ref-2">2</a>]. This suggests that for some, the condition can be well-controlled with a single monthly injection, offering a very good long-term prognosis.

## Limitations and When to Contact a Veterinarian

This article provides a comprehensive overview of Cytopoint, but it has limitations. It cannot predict how your individual dog will respond to the medication. The duration of effect can vary, and what works for one dog may not work for another.

**Contact your veterinarian immediately if:**

- Your dog experiences signs of an allergic reaction after the injection, such as facial swelling, hives, or difficulty breathing.
- Your dog's itching does not improve within 24 to 48 hours of the injection.
- The duration of relief is very short (less than 3 weeks).
- Your dog develops new skin lesions, especially if they are oozing, crusty, or have a foul odor (signs of a secondary infection).
- Your dog's overall condition worsens.

Always consult with your veterinarian before making any changes to your dog's medication schedule. They are the best resource for individualized advice.

## Frequently Asked Questions

### How quickly does Cytopoint start working in dogs?
Cytopoint has a rapid onset of action. Clinical studies have demonstrated a significant reduction in pruritus within 3 to 5 hours after a single subcutaneous injection at the standard 2.0 mg/kg dose [<a href="#ref-1">1</a>].

### How long does one Cytopoint injection last?
The duration of effect is variable but typically lasts between 4 and 8 weeks. Studies show a statistically significant effect for at least 28 days at the standard dose [<a href="#ref-1">1</a>]. Some dogs may experience relief for a median of 63 days, and a subset can go for over a year without a flare [<a href="#ref-2">2</a>].

### What is the standard Cytopoint injection schedule for dogs?
The standard schedule is a single subcutaneous injection every 4 weeks. However, your veterinarian may adjust the interval based on your dog's individual response, extending it to every 6 or 8 weeks if the effect lasts longer [<a href="#ref-2">2</a>][<a href="#ref-1">1</a>].

### What is the active ingredient in Cytopoint?
The active ingredient is lokivetmab, a caninized monoclonal antibody specifically designed to target and neutralize canine Interleukin-31 (IL-31), a key cytokine that triggers itch [<a href="#ref-2">2</a>][<a href="#ref-3">3</a>].

### Is Cytopoint a steroid or an immunosuppressant?
No, Cytopoint is not a steroid. It is a monoclonal antibody that specifically targets IL-31. It does not have the broad immunosuppressive effects of corticosteroids and is considered a very targeted and safe therapy [<a href="#ref-2">2</a>][<a href="#ref-3">3</a>].

### Can Cytopoint be used to prevent allergy flares?
Yes, research supports the use of proactive Cytopoint therapy. In a study, when used proactively, the median time to a flare was 63 days, suggesting it can effectively delay or prevent flares [<a href="#ref-2">2</a>].

### Are there any side effects of Cytopoint injections?
Cytopoint is generally very safe. Side effects are uncommon and usually mild, potentially including temporary lethargy, vomiting, or diarrhea. There is a rare risk of an allergic reaction to the injection itself [<a href="#ref-3">3</a>].

### Is Cytopoint safe to use with other medications?
Yes, Cytopoint is often used safely alongside other treatments such as antibiotics for secondary infections, medicated shampoos, and allergen-specific immunotherapy. Always inform your veterinarian of all medications your dog is receiving.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "How quickly does Cytopoint start working in dogs?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Cytopoint has a rapid onset of action. Clinical studies have demonstrated a significant reduction in pruritus within 3 to 5 hours after a single subcutaneous injection at the standard 2.0 mg/kg dose."
      }
    },
    {
      "@type": "Question",
      "name": "How long does one Cytopoint injection last?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The duration of effect is variable but typically lasts between 4 and 8 weeks. Studies show a statistically significant effect for at least 28 days at the standard dose. Some dogs may experience relief for a median of 63 days, and a subset can go for over a year without a flare."
      }
    },
    {
      "@type": "Question",
      "name": "What is the standard Cytopoint injection schedule for dogs?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The standard schedule is a single subcutaneous injection every 4 weeks. However, your veterinarian may adjust the interval based on your dog's individual response, extending it to every 6 or 8 weeks if the effect lasts longer."
      }
    },
    {
      "@type": "Question",
      "name": "What is the active ingredient in Cytopoint?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The active ingredient is lokivetmab, a caninized monoclonal antibody specifically designed to target and neutralize canine Interleukin-31 (IL-31), a key cytokine that triggers itch."
      }
    },
    {
      "@type": "Question",
      "name": "Is Cytopoint a steroid or an immunosuppressant?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No, Cytopoint is not a steroid. It is a monoclonal antibody that specifically targets IL-31. It does not have the broad immunosuppressive effects of corticosteroids and is considered a very targeted and safe therapy."
      }
    },
    {
      "@type": "Question",
      "name": "Can Cytopoint be used to prevent allergy flares?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, research supports the use of proactive Cytopoint therapy. In a study, when used proactively, the median time to a flare was 63 days, suggesting it can effectively delay or prevent flares."
      }
    },
    {
      "@type": "Question",
      "name": "Are there any side effects of Cytopoint injections?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Cytopoint is generally very safe. Side effects are uncommon and usually mild, potentially including temporary lethargy, vomiting, or diarrhea. There is a rare risk of an allergic reaction to the injection itself."
      }
    },
    {
      "@type": "Question",
      "name": "Is Cytopoint safe to use with other medications?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, Cytopoint is often used safely alongside other treatments such as antibiotics for secondary infections, medicated shampoos, and allergen-specific immunotherapy. Always inform your veterinarian of all medications your dog is receiving."
      }
    }
  ]
}
</script>

## Related Clinical & Scientific Guides

* [Drontal Plus Dewormer: Broad-Spectrum Dose Guide by Weight](/knowledge/veterinary-medicine/calculators-clinical-tools/drontal-plus-dewormer-broad-spectrum-dose-guide-by-weight)
* [Panacur Fenbendazole Dewormer: Dog Fecal Parasite Treatment Schedule](/knowledge/veterinary-medicine/calculators-clinical-tools/panacur-fenbendazole-dewormer-dog-fecal-parasite-treatment-schedule)
* [Prednisolone for Cats: Feline Safe Steroid Dose and Autoimmune](/knowledge/veterinary-medicine/calculators-clinical-tools/prednisolone-for-cats-feline-safe-steroid-dose-and-autoimmune)